Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Hospital Acquired Infection Control Market Growth 2022-2028

  • LP 4925373
  • 101 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Hospital Acquired Infection Control will have significant change from previous year. According to our (LP Information) latest study, the global Hospital Acquired Infection Control market size is USD million in 2022 from USD 5578.1 million in 2021, with a change of % between 2021 and 2022. The global Hospital Acquired Infection Control market size will reach USD 6859.5 million in 2028, growing at a CAGR of 3.0% over the analysis period.

The United States Hospital Acquired Infection Control market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hospital Acquired Infection Control market, reaching US$ million by the year 2028. As for the Europe Hospital Acquired Infection Control landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Hospital Acquired Infection Control players cover Pfizer, Roche, Merck, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Hospital Acquired Infection Control market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Catheter-associated Urinary Tract Infections (CAUTIs)

Surgical Site Infections (SSIs)

Central Line-associated Bloodstream Infections (CLABSIs)

Respiratory Infections

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals and ICUs

Outpatient Care Centers

Long-term Care Facilities (LTCFs)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

Roche

Merck

Johnson & Johnson

Abott

Bayer

BD

Kimberly-Clark

Nordion

Cepheid

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hospital Acquired Infection Control Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Hospital Acquired Infection Control by Country/Region, 2017, 2022 & 2028

2.2 Hospital Acquired Infection Control Segment by Type

2.2.1 Catheter-associated Urinary Tract Infections (CAUTIs)

2.2.2 Surgical Site Infections (SSIs)

2.2.3 Central Line-associated Bloodstream Infections (CLABSIs)

2.2.4 Respiratory Infections

2.3 Hospital Acquired Infection Control Sales by Type

2.3.1 Global Hospital Acquired Infection Control Sales Market Share by Type (2017-2022)

2.3.2 Global Hospital Acquired Infection Control Revenue and Market Share by Type (2017-2022)

2.3.3 Global Hospital Acquired Infection Control Sale Price by Type (2017-2022)

2.4 Hospital Acquired Infection Control Segment by Application

2.4.1 Hospitals and ICUs

2.4.2 Outpatient Care Centers

2.4.3 Long-term Care Facilities (LTCFs)

2.5 Hospital Acquired Infection Control Sales by Application

2.5.1 Global Hospital Acquired Infection Control Sale Market Share by Application (2017-2022)

2.5.2 Global Hospital Acquired Infection Control Revenue and Market Share by Application (2017-2022)

2.5.3 Global Hospital Acquired Infection Control Sale Price by Application (2017-2022)

3 Global Hospital Acquired Infection Control by Company

3.1 Global Hospital Acquired Infection Control Breakdown Data by Company

3.1.1 Global Hospital Acquired Infection Control Annual Sales by Company (2020-2022)

3.1.2 Global Hospital Acquired Infection Control Sales Market Share by Company (2020-2022)

3.2 Global Hospital Acquired Infection Control Annual Revenue by Company (2020-2022)

3.2.1 Global Hospital Acquired Infection Control Revenue by Company (2020-2022)

3.2.2 Global Hospital Acquired Infection Control Revenue Market Share by Company (2020-2022)

3.3 Global Hospital Acquired Infection Control Sale Price by Company

3.4 Key Manufacturers Hospital Acquired Infection Control Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Hospital Acquired Infection Control Product Location Distribution

3.4.2 Players Hospital Acquired Infection Control Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Hospital Acquired Infection Control by Geographic Region

4.1 World Historic Hospital Acquired Infection Control Market Size by Geographic Region (2017-2022)

4.1.1 Global Hospital Acquired Infection Control Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Hospital Acquired Infection Control Annual Revenue by Geographic Region

4.2 World Historic Hospital Acquired Infection Control Market Size by Country/Region (2017-2022)

4.2.1 Global Hospital Acquired Infection Control Annual Sales by Country/Region (2017-2022)

4.2.2 Global Hospital Acquired Infection Control Annual Revenue by Country/Region

4.3 Americas Hospital Acquired Infection Control Sales Growth

4.4 APAC Hospital Acquired Infection Control Sales Growth

4.5 Europe Hospital Acquired Infection Control Sales Growth

4.6 Middle East & Africa Hospital Acquired Infection Control Sales Growth

5 Americas

5.1 Americas Hospital Acquired Infection Control Sales by Country

5.1.1 Americas Hospital Acquired Infection Control Sales by Country (2017-2022)

5.1.2 Americas Hospital Acquired Infection Control Revenue by Country (2017-2022)

5.2 Americas Hospital Acquired Infection Control Sales by Type

5.3 Americas Hospital Acquired Infection Control Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hospital Acquired Infection Control Sales by Region

6.1.1 APAC Hospital Acquired Infection Control Sales by Region (2017-2022)

6.1.2 APAC Hospital Acquired Infection Control Revenue by Region (2017-2022)

6.2 APAC Hospital Acquired Infection Control Sales by Type

6.3 APAC Hospital Acquired Infection Control Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Hospital Acquired Infection Control by Country

7.1.1 Europe Hospital Acquired Infection Control Sales by Country (2017-2022)

7.1.2 Europe Hospital Acquired Infection Control Revenue by Country (2017-2022)

7.2 Europe Hospital Acquired Infection Control Sales by Type

7.3 Europe Hospital Acquired Infection Control Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hospital Acquired Infection Control by Country

8.1.1 Middle East & Africa Hospital Acquired Infection Control Sales by Country (2017-2022)

8.1.2 Middle East & Africa Hospital Acquired Infection Control Revenue by Country (2017-2022)

8.2 Middle East & Africa Hospital Acquired Infection Control Sales by Type

8.3 Middle East & Africa Hospital Acquired Infection Control Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Hospital Acquired Infection Control

10.3 Manufacturing Process Analysis of Hospital Acquired Infection Control

10.4 Industry Chain Structure of Hospital Acquired Infection Control

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Hospital Acquired Infection Control Distributors

11.3 Hospital Acquired Infection Control Customer

12 World Forecast Review for Hospital Acquired Infection Control by Geographic Region

12.1 Global Hospital Acquired Infection Control Market Size Forecast by Region

12.1.1 Global Hospital Acquired Infection Control Forecast by Region (2023-2028)

12.1.2 Global Hospital Acquired Infection Control Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Hospital Acquired Infection Control Forecast by Type

12.7 Global Hospital Acquired Infection Control Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Hospital Acquired Infection Control Product Offered

13.1.3 Pfizer Hospital Acquired Infection Control Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Roche

13.2.1 Roche Company Information

13.2.2 Roche Hospital Acquired Infection Control Product Offered

13.2.3 Roche Hospital Acquired Infection Control Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Roche Main Business Overview

13.2.5 Roche Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Hospital Acquired Infection Control Product Offered

13.3.3 Merck Hospital Acquired Infection Control Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Johnson & Johnson

13.4.1 Johnson & Johnson Company Information

13.4.2 Johnson & Johnson Hospital Acquired Infection Control Product Offered

13.4.3 Johnson & Johnson Hospital Acquired Infection Control Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Johnson & Johnson Main Business Overview

13.4.5 Johnson & Johnson Latest Developments

13.5 Abott

13.5.1 Abott Company Information

13.5.2 Abott Hospital Acquired Infection Control Product Offered

13.5.3 Abott Hospital Acquired Infection Control Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Abott Main Business Overview

13.5.5 Abott Latest Developments

13.6 Bayer

13.6.1 Bayer Company Information

13.6.2 Bayer Hospital Acquired Infection Control Product Offered

13.6.3 Bayer Hospital Acquired Infection Control Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bayer Main Business Overview

13.6.5 Bayer Latest Developments

13.7 BD

13.7.1 BD Company Information

13.7.2 BD Hospital Acquired Infection Control Product Offered

13.7.3 BD Hospital Acquired Infection Control Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 BD Main Business Overview

13.7.5 BD Latest Developments

13.8 Kimberly-Clark

13.8.1 Kimberly-Clark Company Information

13.8.2 Kimberly-Clark Hospital Acquired Infection Control Product Offered

13.8.3 Kimberly-Clark Hospital Acquired Infection Control Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Kimberly-Clark Main Business Overview

13.8.5 Kimberly-Clark Latest Developments

13.9 Nordion

13.9.1 Nordion Company Information

13.9.2 Nordion Hospital Acquired Infection Control Product Offered

13.9.3 Nordion Hospital Acquired Infection Control Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Nordion Main Business Overview

13.9.5 Nordion Latest Developments

13.10 Cepheid

13.10.1 Cepheid Company Information

13.10.2 Cepheid Hospital Acquired Infection Control Product Offered

13.10.3 Cepheid Hospital Acquired Infection Control Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Cepheid Main Business Overview

13.10.5 Cepheid Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Hospital Acquired Infection Control Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Hospital Acquired Infection Control Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Catheter-associated Urinary Tract Infections (CAUTIs)

Table 4. Major Players of Surgical Site Infections (SSIs)

Table 5. Major Players of Central Line-associated Bloodstream Infections (CLABSIs)

Table 6. Major Players of Respiratory Infections

Table 7. Global Hospital Acquired Infection Control Sales by Type (2017-2022) & (K Units)

Table 8. Global Hospital Acquired Infection Control Sales Market Share by Type (2017-2022)

Table 9. Global Hospital Acquired Infection Control Revenue by Type (2017-2022) & ($ million)

Table 10. Global Hospital Acquired Infection Control Revenue Market Share by Type (2017-2022)

Table 11. Global Hospital Acquired Infection Control Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Hospital Acquired Infection Control Sales by Application (2017-2022) & (K Units)

Table 13. Global Hospital Acquired Infection Control Sales Market Share by Application (2017-2022)

Table 14. Global Hospital Acquired Infection Control Revenue by Application (2017-2022)

Table 15. Global Hospital Acquired Infection Control Revenue Market Share by Application (2017-2022)

Table 16. Global Hospital Acquired Infection Control Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Hospital Acquired Infection Control Sales by Company (2020-2022) & (K Units)

Table 18. Global Hospital Acquired Infection Control Sales Market Share by Company (2020-2022)

Table 19. Global Hospital Acquired Infection Control Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Hospital Acquired Infection Control Revenue Market Share by Company (2020-2022)

Table 21. Global Hospital Acquired Infection Control Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Hospital Acquired Infection Control Producing Area Distribution and Sales Area

Table 23. Players Hospital Acquired Infection Control Products Offered

Table 24. Hospital Acquired Infection Control Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Hospital Acquired Infection Control Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Hospital Acquired Infection Control Sales Market Share Geographic Region (2017-2022)

Table 29. Global Hospital Acquired Infection Control Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Hospital Acquired Infection Control Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Hospital Acquired Infection Control Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Hospital Acquired Infection Control Sales Market Share by Country/Region (2017-2022)

Table 33. Global Hospital Acquired Infection Control Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Hospital Acquired Infection Control Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Hospital Acquired Infection Control Sales by Country (2017-2022) & (K Units)

Table 36. Americas Hospital Acquired Infection Control Sales Market Share by Country (2017-2022)

Table 37. Americas Hospital Acquired Infection Control Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Hospital Acquired Infection Control Revenue Market Share by Country (2017-2022)

Table 39. Americas Hospital Acquired Infection Control Sales by Type (2017-2022) & (K Units)

Table 40. Americas Hospital Acquired Infection Control Sales Market Share by Type (2017-2022)

Table 41. Americas Hospital Acquired Infection Control Sales by Application (2017-2022) & (K Units)

Table 42. Americas Hospital Acquired Infection Control Sales Market Share by Application (2017-2022)

Table 43. APAC Hospital Acquired Infection Control Sales by Region (2017-2022) & (K Units)

Table 44. APAC Hospital Acquired Infection Control Sales Market Share by Region (2017-2022)

Table 45. APAC Hospital Acquired Infection Control Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Hospital Acquired Infection Control Revenue Market Share by Region (2017-2022)

Table 47. APAC Hospital Acquired Infection Control Sales by Type (2017-2022) & (K Units)

Table 48. APAC Hospital Acquired Infection Control Sales Market Share by Type (2017-2022)

Table 49. APAC Hospital Acquired Infection Control Sales by Application (2017-2022) & (K Units)

Table 50. APAC Hospital Acquired Infection Control Sales Market Share by Application (2017-2022)

Table 51. Europe Hospital Acquired Infection Control Sales by Country (2017-2022) & (K Units)

Table 52. Europe Hospital Acquired Infection Control Sales Market Share by Country (2017-2022)

Table 53. Europe Hospital Acquired Infection Control Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Hospital Acquired Infection Control Revenue Market Share by Country (2017-2022)

Table 55. Europe Hospital Acquired Infection Control Sales by Type (2017-2022) & (K Units)

Table 56. Europe Hospital Acquired Infection Control Sales Market Share by Type (2017-2022)

Table 57. Europe Hospital Acquired Infection Control Sales by Application (2017-2022) & (K Units)

Table 58. Europe Hospital Acquired Infection Control Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Hospital Acquired Infection Control Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Hospital Acquired Infection Control Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Hospital Acquired Infection Control Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Hospital Acquired Infection Control Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Hospital Acquired Infection Control Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Hospital Acquired Infection Control Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Hospital Acquired Infection Control Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Hospital Acquired Infection Control Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Hospital Acquired Infection Control

Table 68. Key Market Challenges & Risks of Hospital Acquired Infection Control

Table 69. Key Industry Trends of Hospital Acquired Infection Control

Table 70. Hospital Acquired Infection Control Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Hospital Acquired Infection Control Distributors List

Table 73. Hospital Acquired Infection Control Customer List

Table 74. Global Hospital Acquired Infection Control Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Hospital Acquired Infection Control Sales Market Forecast by Region

Table 76. Global Hospital Acquired Infection Control Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Hospital Acquired Infection Control Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Hospital Acquired Infection Control Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Hospital Acquired Infection Control Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Hospital Acquired Infection Control Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Hospital Acquired Infection Control Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Hospital Acquired Infection Control Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Hospital Acquired Infection Control Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Hospital Acquired Infection Control Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Hospital Acquired Infection Control Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Hospital Acquired Infection Control Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Hospital Acquired Infection Control Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Hospital Acquired Infection Control Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Hospital Acquired Infection Control Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Hospital Acquired Infection Control Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Hospital Acquired Infection Control Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Hospital Acquired Infection Control Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Hospital Acquired Infection Control Revenue Market Share Forecast by Application (2023-2028)

Table 94. Pfizer Basic Information, Hospital Acquired Infection Control Manufacturing Base, Sales Area and Its Competitors

Table 95. Pfizer Hospital Acquired Infection Control Product Offered

Table 96. Pfizer Hospital Acquired Infection Control Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Pfizer Main Business

Table 98. Pfizer Latest Developments

Table 99. Roche Basic Information, Hospital Acquired Infection Control Manufacturing Base, Sales Area and Its Competitors

Table 100. Roche Hospital Acquired Infection Control Product Offered

Table 101. Roche Hospital Acquired Infection Control Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Roche Main Business

Table 103. Roche Latest Developments

Table 104. Merck Basic Information, Hospital Acquired Infection Control Manufacturing Base, Sales Area and Its Competitors

Table 105. Merck Hospital Acquired Infection Control Product Offered

Table 106. Merck Hospital Acquired Infection Control Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Merck Main Business

Table 108. Merck Latest Developments

Table 109. Johnson & Johnson Basic Information, Hospital Acquired Infection Control Manufacturing Base, Sales Area and Its Competitors

Table 110. Johnson & Johnson Hospital Acquired Infection Control Product Offered

Table 111. Johnson & Johnson Hospital Acquired Infection Control Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Johnson & Johnson Main Business

Table 113. Johnson & Johnson Latest Developments

Table 114. Abott Basic Information, Hospital Acquired Infection Control Manufacturing Base, Sales Area and Its Competitors

Table 115. Abott Hospital Acquired Infection Control Product Offered

Table 116. Abott Hospital Acquired Infection Control Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Abott Main Business

Table 118. Abott Latest Developments

Table 119. Bayer Basic Information, Hospital Acquired Infection Control Manufacturing Base, Sales Area and Its Competitors

Table 120. Bayer Hospital Acquired Infection Control Product Offered

Table 121. Bayer Hospital Acquired Infection Control Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Bayer Main Business

Table 123. Bayer Latest Developments

Table 124. BD Basic Information, Hospital Acquired Infection Control Manufacturing Base, Sales Area and Its Competitors

Table 125. BD Hospital Acquired Infection Control Product Offered

Table 126. BD Hospital Acquired Infection Control Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. BD Main Business

Table 128. BD Latest Developments

Table 129. Kimberly-Clark Basic Information, Hospital Acquired Infection Control Manufacturing Base, Sales Area and Its Competitors

Table 130. Kimberly-Clark Hospital Acquired Infection Control Product Offered

Table 131. Kimberly-Clark Hospital Acquired Infection Control Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Kimberly-Clark Main Business

Table 133. Kimberly-Clark Latest Developments

Table 134. Nordion Basic Information, Hospital Acquired Infection Control Manufacturing Base, Sales Area and Its Competitors

Table 135. Nordion Hospital Acquired Infection Control Product Offered

Table 136. Nordion Hospital Acquired Infection Control Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Nordion Main Business

Table 138. Nordion Latest Developments

Table 139. Cepheid Basic Information, Hospital Acquired Infection Control Manufacturing Base, Sales Area and Its Competitors

Table 140. Cepheid Hospital Acquired Infection Control Product Offered

Table 141. Cepheid Hospital Acquired Infection Control Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Cepheid Main Business

Table 143. Cepheid Latest Developments

List of Figures

Figure 1. Picture of Hospital Acquired Infection Control

Figure 2. Hospital Acquired Infection Control Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Hospital Acquired Infection Control Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Hospital Acquired Infection Control Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Hospital Acquired Infection Control Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Catheter-associated Urinary Tract Infections (CAUTIs)

Figure 10. Product Picture of Surgical Site Infections (SSIs)

Figure 11. Product Picture of Central Line-associated Bloodstream Infections (CLABSIs)

Figure 12. Product Picture of Respiratory Infections

Figure 13. Global Hospital Acquired Infection Control Sales Market Share by Type in 2021

Figure 14. Global Hospital Acquired Infection Control Revenue Market Share by Type (2017-2022)

Figure 15. Hospital Acquired Infection Control Consumed in Hospitals and ICUs

Figure 16. Global Hospital Acquired Infection Control Market: Hospitals and ICUs (2017-2022) & (K Units)

Figure 17. Hospital Acquired Infection Control Consumed in Outpatient Care Centers

Figure 18. Global Hospital Acquired Infection Control Market: Outpatient Care Centers (2017-2022) & (K Units)

Figure 19. Hospital Acquired Infection Control Consumed in Long-term Care Facilities (LTCFs)

Figure 20. Global Hospital Acquired Infection Control Market: Long-term Care Facilities (LTCFs) (2017-2022) & (K Units)

Figure 21. Global Hospital Acquired Infection Control Sales Market Share by Application (2017-2022)

Figure 22. Global Hospital Acquired Infection Control Revenue Market Share by Application in 2021

Figure 23. Hospital Acquired Infection Control Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Hospital Acquired Infection Control Revenue Market Share by Company in 2021

Figure 25. Global Hospital Acquired Infection Control Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Hospital Acquired Infection Control Revenue Market Share by Geographic Region in 2021

Figure 27. Global Hospital Acquired Infection Control Sales Market Share by Region (2017-2022)

Figure 28. Global Hospital Acquired Infection Control Revenue Market Share by Country/Region in 2021

Figure 29. Americas Hospital Acquired Infection Control Sales 2017-2022 (K Units)

Figure 30. Americas Hospital Acquired Infection Control Revenue 2017-2022 ($ Millions)

Figure 31. APAC Hospital Acquired Infection Control Sales 2017-2022 (K Units)

Figure 32. APAC Hospital Acquired Infection Control Revenue 2017-2022 ($ Millions)

Figure 33. Europe Hospital Acquired Infection Control Sales 2017-2022 (K Units)

Figure 34. Europe Hospital Acquired Infection Control Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Hospital Acquired Infection Control Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Hospital Acquired Infection Control Revenue 2017-2022 ($ Millions)

Figure 37. Americas Hospital Acquired Infection Control Sales Market Share by Country in 2021

Figure 38. Americas Hospital Acquired Infection Control Revenue Market Share by Country in 2021

Figure 39. United States Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Hospital Acquired Infection Control Sales Market Share by Region in 2021

Figure 44. APAC Hospital Acquired Infection Control Revenue Market Share by Regions in 2021

Figure 45. China Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Hospital Acquired Infection Control Sales Market Share by Country in 2021

Figure 52. Europe Hospital Acquired Infection Control Revenue Market Share by Country in 2021

Figure 53. Germany Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Hospital Acquired Infection Control Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Hospital Acquired Infection Control Revenue Market Share by Country in 2021

Figure 60. Egypt Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Hospital Acquired Infection Control Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Hospital Acquired Infection Control in 2021

Figure 66. Manufacturing Process Analysis of Hospital Acquired Infection Control

Figure 67. Industry Chain Structure of Hospital Acquired Infection Control

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450